AMRX - Amneal Pharmaceuticals Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.941B

Cash

148M

Avg Qtr Burn

N/A

Short % of Float

3.89%

Insider Ownership

10.87%

Institutional Own.

64.00%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RELEUKO® (filgrastim-ayow) Details Chemotherapy-induced neutropenia	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Naloxone Hydrochloride Nasal Spray Details Parkinson's disease	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IPX203 Details Parkinson's disease Big Mover™ Suspected Mover™ Susp. Mover™	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.